Cent Eur Neurosurg 2010; 71(4): 173-180
DOI: 10.1055/s-0030-1249698
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Expression of Invasion-Related Extracellular Matrix Molecules in Human Glioblastoma Versus Intracerebral Lung Adenocarcinoma Metastasis

I. Varga1 , G. Hutóczki2 , M. Petrás3 , B. Scholtz4 , E. Mikó4 , A. Kenyeres5 , J. Tóth6 , G. Zahuczky4 , L. Bognár2 , Z. Hanzély7 , A. Klekner2
  • 1Kenezy Hospital, Debrecen, Department of Pulmonology, Debrecen, Hungary
  • 2University of Debrecen, Department of Neurosurgery, Debrecen, Hungary
  • 3Medical and Health Science Center, University of Debrecen, Biophysics and Cell Biology, Debrecen, Hungary
  • 4University of Debrecen, Department of Biochemistry and Molecular Biology, Debrecen, Hungary
  • 5University of Debrecen, Department of Anatomy, Histology and Embryology, Debrecen, Hungary
  • 6University of Debrecen, Department of Oncology, Debrecen, Hungary
  • 7National Institute of Neurosurgery, Department of Pathology, Budapest, Hungary
Further Information

Publication History

Publication Date:
15 April 2010 (online)

Abstract

Tumor cell invasion into the surrounding brain tissue is mainly responsible for the failure of radical surgical resection, with tumor recurrence in the form of microdisseminated disease. Extracellular matrix (ECM)-related molecules and their receptors predominantly participate in the invasion process, including cell adhesion to the surrounding microenvironment and cell migration. The extent of infiltration of the healthy brain by malignant tumors strongly depends on the tumor cell type. Malignant gliomas show much more intensive peritumoral invasion than do metastatic tumors. In this study, the mRNA expression of 30 invasion-related molecules (twenty-one ECM components, two related receptors, and seven ECM-related enzymes) was investigated by quantitative reverse transcriptase-polymerase chain reaction. Fresh frozen human tissue samples from glioblastoma (GBM), intracerebral lung adenocarcinoma metastasis, and normal brain were evaluated. Significant differences were established for 24 of the 30 molecules. To confirm our results at the protein level, immunohistochemical analysis of seven molecules was performed (agrin, neurocan, syndecan, versican, matrix metalloproteinase 2 [MMP-2], MMP-9, and hyaluronan). Determining the differences in the levels of invasion-related molecules for tumors of different origins can help to identify the exact molecular mechanisms that facilitate peritumoral infiltration by glioblastoma cells. These results should allow the selection of target molecules for potential chemotherapeutic agents directed against highly invasive malignant gliomas.

References

  • 1 Akita K, Toda M, Hosoki Y. et al . Heparan sulphate PGs interact with neurocan and promote neurite outgrowth from cerebellar granule cells.  Biochem J. 2004;  383 129-138
  • 2 Aono S. Expression and identification of a new splice variant of neuroglycan C, a transmembrane chondroitin sulfate PG, in the human brain.  J Neurosci Res. 2006;  83 110-118
  • 3 Arnold SM. Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.  Clin Cancer Res. 1999;  5 4028-4033
  • 4 Bellail AC, Hunter SB, Brat DJ. et al . Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.  Int J Biochem Cell Biol. 2004;  36 1046-1069
  • 5 Burger PC, Scheithauer BW. Tumors of the central nervous system.  Atlas of Tumor Pathology, third series, fascicle. 1994;  10 349-369
  • 6 Czirok A, Zamir EA, Filla MB. et al . Extracellular matrix macroassembly dynamics in early vertebrate embryos.  Curr Top Dev Biol. 2006;  73 237-258
  • 7 Delpech B, Maingonnat C, Girard N. et al . Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumor stroma.  Eur J Cancer. 1993;  29 1012-1017
  • 8 Fears CY, Gladson CL, Woods A. Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells.  J Biol Chem. 2006;  281 14533-14536
  • 9 Felszeghy S, Hyttinen M, Tammi R. et al . Quantitative image analysis of hyaluronan expression in human tooth germs.  Eur J Oral Sci. 2000;  108 320-326
  • 10 Gary SC, Hockfield S. BEHAB/brevican: an extracellular matrix component associated with invasive glioma.  Clin Neurosurg. 2000;  47 72-82
  • 11 Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology.  J Neuro-Oncol. 2005;  75 5-14
  • 12 Gladson CL. The extracellular matrix of gliomas: Modulation of cell function.  J Neuropath Exp Neurol. 1999;  58 1029-1040
  • 13 Guo P, Imanishi Y, Cackowski FC. et al . Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.  Am J Pathol. 2005;  166 877-890
  • 14 Han JY, Kim HS, Lee SH. et al . Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis.  Lung Cancer. 2003;  41 65-70
  • 15 Han S, Sidell N, Roman J. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.  Cancer Lett. 2003;  219 71-81
  • 16 Higuchi M, Ohnishi T, Arita N. et al . Expression of tenascin in human gliomas: Its relation to histological malignancy.  Acta Neuropath (Berlin). 1993;  85 481-487
  • 17 Hirose J, Kawashima H, Yoshie O. et al . Versican interacts with chemokines and modulates cellular responses.  J Biol Chem. 2001;  276 5228-5234
  • 18 Jung S, Moon KS, Kim ST. et al . Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema.  J Clin Neurosci. 2007;  14 1192-1198
  • 19 Khan ZA, Caurtero J, Barbin YP Chan BM. et al . ED-B fibronectin in non-small cell lung carcinoma.  Exp Lung Res. 2005;  31 701-711
  • 20 Kinugasa Y. . Neuroglycan C, a novel member of the neuregulin family.  Biochem Biophys Res Commun. 2004;  321 1045-1049
  • 21 Lee LN, Kuo SH, Lee YC. et al . CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.  J Formos Med Assoc. 2005;  104 541-548
  • 22 Leivonen M, Lundin J, Nordling S. et al . Prognostic value of syndecan-1 expression in breast cancer.  Oncology. 2004;  67 11-18
  • 23 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method.  Methods. 2001;  25 402-408
  • 24 Louis DN, Ohgaki H, Wiestler OD. et al . The 2007 WHO classification of tumours of the central nervous system.  Acta Neuropathol. 2007;  114 197-109
  • 25 Mahesparan R, Read TA, Lund-Johansen M. et al . Expression of extracellular matrix components in a highly infiltrative in vivo glioma model.  Acta Neuropathol. 2003;  105 49-57
  • 26 Miliaras G, Tsitsopoulos PP, Markoula S. et al . Multifocal glioblastoma with remote cutaneous metastasis: a case report and review of the literature.  Cen Eur Neurosurg. 2009;  70 39-42
  • 27 Nackaerts K, Verbeken E, Deneffe G. et al . Heparan sulfate PG expression in human lung-cancer cells.  Int J Cancer. 1997;  74 335-345
  • 28 Niki T, Kohno T, Iba S. et al . Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.  Am J Pathol. 2002;  160 1129-1141
  • 29 Nutt CL, Matthews RT, Hockfield S. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.  Neuroscientist. 2001;  7 113-122
  • 30 Oz B, Karayel FA, Gazio NL. et al . The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.  Path Oncol Res. 2000;  6 118-124
  • 31 Pakula R, Melchior A, Denys A. et al . Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis.  Glycobiology. 2007;  17 492-503
  • 32 Paulus W. Differential expression of versican isoforms in brain tumors.  J Neuropathol Exp Neurol. 1996;  55 528-533
  • 33 Pirinen R, Leinonen T, Bohm J. et al . Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis.  Hum Pathol. 2005;  36 44-50
  • 34 Pirinen R, Tammi R, Tammi M. et al . Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma.  Int J Cancer. 2001;  95 12-17
  • 35 Ranuncolo SM, Ladeda V, Specterman S. et al . CD44 expression in human gliomas.  J Surg Oncol. 2002;  79 30-35
  • 36 Rascher G, Fischmann A, Kroger S. et al . Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin.  Acta Neuropathol (Berl). 2002;  104 85-91
  • 37 Sainte-Marie G. A paraffin embedding technique for studies employing immunofluorescence.  J Histochem Cytochem. 1962;  10 250-256
  • 38 Shah L, Walter KL, Borczuk AC. et al . Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.  Cancer. 2004;  101 1632-1638
  • 39 Shibata Sh, Fukada K, Suzuki Sh. et al . Histochemical localisation of versican, aggrecan and hyaluronan in the developing condylar cartilage of the fetal rat mandible.  J Anat. 2001;  198 129-135
  • 40 Sunami E, Tsuno N, Osada T. et al . MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer.  The Oncologist. 2000;  5 108-114
  • 41 Szelachowska J, Jelen M, Kornafel J. Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer.  Anticancer Res. 2006;  26 3871-3876
  • 42 Tammi R, Ripellino JA, Margolis RU. et al . Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture.  J Invest Dermatol. 1989;  92 326-332
  • 43 Tews DS. Adhesive and invasive features in gliomas.  Pathol Res Pract. 2000;  196 701-711
  • 44 Tuckett F, Morriss-Kay G. Alcian blue staining of glycosaminoglycans in embryonic material: effect of different fixatives.  Histochem J. 1988;  20 174-182
  • 45 Viapiano MS, Bi WL, Piepmeier J. et al . Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.  Cancer Res. 2005;  65 6726-6733
  • 46 Viapiano MS, Hockfield S, Matthews RT. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.  J Neurooncol. 2008;  88 261-272
  • 47 Warth A. Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors.  Acta Neuropathol (Berl). 2005;  109 418-426
  • 48 Watanabe A. Expression of syndecans, a heparan sulfate PG, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.  J Neurooncol. 2006;  77 25-33
  • 49 Wiranowska M, Ladd S, Smith SR. et al . CD44 adhesion molecule and neuro-glial PG NG2 as invasive markers of glioma.  Brain Cell Biol. 2006;  35 159-172
  • 50 Xiang YY. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor.  J Biol Chem. 2006;  281 19358-19368
  • 51 Yee AJ, Akens M, Yang BL. et al . The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.  Breast Cancer Research. 2007;  9 R47
  • 52 Zagzag D, Friedlander DR, Dosik J. et al . Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro.  Cancer Res. 1996;  56 182-189
  • 53 Zinzindohoué F, Lecomte Th, Ferraz J-M. et al . Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.  Clin Cancer Res. 2005;  11 594-599

Correspondence

Dr. A. Klekner

University of Debrecen MHSC Hungary

Department of Neurosurgery

4030 Debrecen

Nagyerdei krt 98

4032 Debrecen

Hungary

Phone: +36/52/419 418

Fax: +36/52/419 418

Email: aklekner@yahoo.com